SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,134.01 |
| Enterprise Value ($M) | 3,274.87 |
| Book Value ($M) | 160.17 |
| Book Value / Share | 0.54 |
| Price / Book | 19.57 |
| NCAV ($M) | -134.65 |
| NCAV / Share | -0.46 |
| Price / NCAV | -23.28 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.25 |
| Return on Assets (ROA) | -0.22 |
| Return on Equity (ROE) | -1.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.52 |
| Current Ratio | 2.88 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 483.06 |
| Assets | 777.88 |
| Liabilities | 617.71 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 399.36 |
| Operating Income | -73.49 |
| Net Income | -151.58 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -69.09 |
| Cash from Investing | 98.06 |
| Cash from Financing | 61.68 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Redmile Group, LLC | 7.30 | -23.22 | |
| 13G/A | Perceptive Advisors Llc | 9.60 | 1.50 | |
| 13G/A | Avoro Capital Advisors LLC | 9.30 | 2.24 | |
| 13G/A | Vanguard Group Inc | 9.72 | 7.36 | |
| 13G | Wellington Management Group Llp | 5.18 | 87.36 | |
| 13G/A | BlackRock Inc. | 7.80 | 14.16 | |
| 13G | Jpmorgan Chase & Co | 5.90 | 30.02 | |
| 13G/A | Morgan Stanley | 4.20 | -30.03 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 223,331 | 1,248,790 | 17.88 | |
| 327,853 | 959,852 | 34.16 | |
| 140,396 | 929,360 | 15.11 | |
| 108,884 | 3,013,059 | 3.61 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FATE – Fate Therapeutics, Inc. | FBLG – FibroBiologics, Inc. |
| FHTX – Foghorn Therapeutics Inc. | FULC – Fulcrum Therapeutics, Inc. |
| GANX – Gain Therapeutics, Inc. |